Ga. Comp. R. & Regs. R. 480-34-.11 - Levocetirizine Dihydrochloride
(1) This rule was adopted to protect the
health, safety, and welfare of the public. Levocetirizine dihydrochloride in 5
mg tablets or an oral solution of 2.5 mg per 5 mL (.05 mg per mL), as
identified in Official Code of Georgia Annotated (O.C.G.A.) §
16-13-71(b)(516.75),
is hereby removed from the list of dangerous drugs of the Georgia Dangerous
Drugs Act.
(2) This rule is based
on the following findings of the Board:
(a)
that levocetirizine dihydrochloride does not have a high potential for
abuse;
(b) that the Board has
considered the scientific evidence of its pharmacological effects; the state of
current scientific knowledge regarding the drug; the history and current
pattern of abuse; the scope, duration, and significance of abuse; the potential
of the drug to produce psychic or physiological dependence liability;
and
(c) that the drug, when in 5 mg
tablets or an oral solution of 2.5 mg per 5 mL (.05 mg per mL), has been
approved for non-prescription status by the Federal Food and Drug
Administration.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.